Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
American College of Obstetricians and Gynecologists

2. Address

Address1
409 12th Street, SW
 Address2
​
City
Washington
 State
DC
 Zip Code
20024
 Country
USA

3. Principal place of business (if different than line 2)

City
​Washington
 State
​DC
 Zip Code
​20024
 Country
​USA
4a. Contact Name b. Telephone Number c. E-mail
​Ms.
​Kira Peterson
​2023142356
​kpeterson@acog.org
5. Senate ID#
​400578740-12
7. Client Name Self Check if client is a state or local government or instrumentality
​American College of Obstetricians and Gynecologists
6. House ID#
​412490000
TYPE OF REPORT 8. Year
​2025
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​210,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Kira Peterson
 Date
7/18/2025 4:13:17 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code AGR

16. Specific lobbying issues

WIC (general); SNAP (general)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Lillie
Heyman
​
​
Sarah
Bogdan
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Womens health research (general); Centers for Disease Control and Prevention (CDC); National Institutes of Health (NIH); NIH Office of Research on Womens Health; Health Resources and Services Administration (HRSA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Alliance for Innovation on Maternal Health (HRSA); Safe Motherhood and Infant Health Program (CDC); National Center for Chronic Disease Prevention and Health Promotion (CDC); Substance Abuse and Mental Health Services Administration (SAMHSA); Agency for Healthcare Research and Quality (AHRQ); National Center for Health Statistics (NCHS); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC); inclusion of pregnant and lactating people in clinical trials (general); Congressionally Directed Medical Research Program; Title X family planning program; CDC Division of Sexually Transmitted Disease Prevention; Prevention and Public Health Fund; Title V Maternal and Child Health Block Grant; Title VII Health Professions and Title VIII Nursing Workforce Development programs; Medicaid free choice of provider requirement; research into firearm morbidity and mortality prevention at CDC and NIH; rural obstetrics emergency readiness training and grants; neglected surgical conditions (general); IHS loan repayment and scholarship programs; IHS staff quarters; IHS medical and diagnostic equipment; Teen Pregnancy Prevention Program; National Center for Environmental Health (CDC); Office on Smoking and Health (CDC); Pregnancy Risk Assessment Monitoring System (CDC); Pregnancy Mortality Surveillance System (CDC); IMPROVE Initiative (NIH); womens health research workforce development programs; public health data modernization at CDC; NIH restructuring (general); SET-NET (CDC); Center for Substance Abuse Treatment Pregnant and Postpartum Womens Residential Services Grant Program (SAMHSA); State Pilot Program for Treatment for Pregnant and Postpartum Women (SAMHSA)
FY2026 Labor, Health and Human Services, and Education, and Related Agencies appropriations bill; FY 2026 Defense Appropriations Bill

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Defense - Dept of (DOD)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Rachel
Tetlow
​
​
Sarah
Bogdan
​
​
Rebecca
Lauer
​
​
Lillie
Heyman
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code EDU

16. Specific lobbying issues

Federal student loan programs (general); Grad PLUS loans (general); student loan interest deferral (general); H.R. 1, One Big, Beautiful Bill Act.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Rebecca
Lauer
​
​
Lillie
Heyman
​
​
Sarah
Bogdan
​
​
Rachel
Tetlow
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); Advancing Safe Medications for Moms and Babies Act; Inclusion of pregnant and lactating individuals in research (general); Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; Teaching Health Center Graduate Medication Education program (general); H.R. 1, One Big, Beautiful Bill Act; H.R. 1909, Preventing Maternal Deaths Reauthorization Act of 2025; Telemedicine (general); SHINE for Autumn Act; S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 2059, Keeping Obstetrics Local Act; S. 2035, Protect IVF Act; H.R.3890, Resident Physician Shortage Reduction Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act; Uterine Fibroid Intervention and Gynecological Health Treatment Act; S. 2004, Maternal and Infant Syphilis Prevention Act; H.R.3514/ S. 1816, Improving Seniors Timely Access to Care Act;S.1866 / H.R.2381, SCREENS for Cancer Act; H.R. 4084, Access to Birth Control Act; S. 942/H.R. 2028, REDI Act; Implementation of P.L. 117-328, Pregnant Workers Fairness Act; National Health Service Corps (general); Public Service Loan Forgiveness program (general maternal mortality review committees (general); HIPAA (general); reductions in force at HHS (general); caps on indirect research costs at NIH (general); removal of CDC online guidance (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); NIH/NICHD womens health research (general); access to fertility services and treatments (general); funding for providers of reproductive health care (general); Richardson Waiver; IUD insertion (general); health IT (general); prepregnancy health (general); Affordable Care Act (general); H.R. 3701, Family Vaccine Protection Act; Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); H.R. 4104/S. 2149, HEAL for Immigrant Families Act.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP), Centers For Disease Control & Prevention (CDC)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Rachel
Tetlow
​
​
Sarah
Bogdan
​
​
Rebecca
Lauer
​
​
Lillie
Heyman
​
​
Lisa
Satterfield
​
​
Taylor
Platt
​
​
Erin
Alston
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; Physician payment under Medicare (general); Graduate medical education (general); Prior authorization in Medicare (general); Medicaid (general); Medicaid free choice of provider requirement; Implementation of P.L. 117-328, Consolidated Appropriations Act, including permanent option for postpartum Medicaid extension; Physician reimbursements under Medicaid (general); Medicaid expansion (general); Medicaid work requirements (general); CMS billing and coding procedures (general); H.R. 1, One Big, Beautiful Bill Act.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Rachel
Tetlow
​
​
Sarah
Bogdan
​
​
Rebecca
Lauer
​
​
Lillie
Heyman
​
​
Lisa
Satterfield
​
​
Taylor
Platt
​
​
Erin
Alston
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Pass-Through Entity Tax (PTET) deduction; H.R. 1, One Big, Beautiful Bill Act.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Sarah
Bogdan
​
​
Lillie
Heyman
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)